Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6800
-0.0200 (-2.86%)
At close: Jan 16, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 44.13 million as of January 16, 2026. Its market cap has increased by 83.05% in one year.
Market Cap
44.13M
Enterprise Value
34.38M
Revenue
20.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.68
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 44.13M, a decrease of -81.26%. That is a compound annual growth rate of -32.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 44.13M | -0.35% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 1.06T |
| Atlas Copco AB | 878.28B |
| AB Volvo | 641.69B |
| EQT AB | 426.36B |
| Sandvik AB | 412.07B |
| ASSA ABLOY AB | 410.32B |
| Skandinaviska Enskilda Banken AB | 398.52B |
| Swedbank AB | 388.64B |